Don’t miss the latest developments in business and finance.

IOLCP wins National Energy Conservation Award 2010

Distinction of winning the prestigious award for sixth year in a row

Image
Announcement Corporate
Last Updated : Jan 21 2013 | 6:57 AM IST

IOL Chemicals and Pharmaceuticals Limited (IOLCP), producers of APIs; Ibuprofen and specialty chemicals has announced that the company has once again won the National Energy Conservation Award 2010. The company has won the FIRST PRIZE in Drugs & Pharmaceuticals Sector for its continued efforts towards new technology implementation so as to conserve energy resources of the country.  It is worth noting that winning the National Energy Conservation Award 2010 has enabled IOLCP to hold the distinction to have won the National Energy Conservation Awards consecutively for six years. IOLCP has won the second prize of National Energy Conservation Award every year since 2005. 

Mr. RK Thukral, Executive Director, IOLCP received the award from Mr. Sushil Kumar Shinde, Hon’ble Minister of Power, Government of India at a special felicitation ceremony held on December 14, 2010, National Energy Conservation Day, at New Delhi. 

According to Mr. R K Thukral, Executive Director, IOLCP, “It is an honour for us that our sustained efforts towards energy conservation have been recognized through this award yet once again. This year, we have achieved considerable decline in energy consumption at our manufacturing units due to implementation of a number of energy conservation measures and ideas to increase the power-efficiency of our equipment and processes. We are committed towards further improving our performance and achieving higher standards in this critical area of operations.”

The National Energy Conservation Awards are given every year by the Ministry of Power, Government of India, to industrial units, office buildings, hotels and hospitals, zonal railways, state designated agencies, municipalities, and manufacturers of BEE Star labeled appliances that have made commendable efforts in energy conservation in their respective fields.

“IOLCP, considers it a duty to avoid any wastage and precious energy resources as we believe that their sustained conserve availability will shape growth of India,” added Mr. Thukral.

Apart from the energy conservation initiatives at IOLCP, the company is also actively involved in protection and preservation of the environment in and around its manufacturing units. The company’s environmental policy includes sustained efforts towards minimizing adverse environmental impact by controlling emission, effluents and waste generation at its manufacturing units in order to prevent pollution and reduce its carbon footprint. 

According to Mr. Thukral, we understand and appreciate our role in environment conservation. We are committed to incorporate environmental management in all our business processes and practices and make a much wider contribution towards this cause in the coming few years.”

More From This Section

The company also emphasizes on optimum utilization of resources through model business practices that include diligent recovery of solvents, improvement in the yields, energy and water. The company also invests regularly in continuously upgrading its Environment Management System (EMS) and its operating standards to comply with applicable legalization and regulations.

About IOL Chemicals and Pharmaceuticals Limited
Established in 1986, IOLCP, a public-listed company (NSE and BSE), is one of the largest manufacturers of APIs and specialty chemicals with presence in over 55 countries across the world. IOLCP manufactures and supplies APIs and specialty chemicals for use in various pharmaceutical, Textile, Packaging, Lamination, Pesticides and Food processing applications.

IOLCP’s product portfolio includes APIs; Ibuprofen, specialty chemicals such as ethyl acetate, acetic anhydride, Iso Butyl Benzene, Mono Chloro Acetic Acid and Acetyl Chloride and bulk chemicals such as Glacial Acetic acid. 

IOLCP is currently in a phase of expansion with an investment outlay of Rs. 130 crore which would include diversifying into other generic products and manufacturing Proton Pumps Inhibitors (PPI’s), an anti-ulcer segment and to install a Multi Purpose plant in which, the company can able to manufacture alternative intermediate products depending upon the demand and margins.

IOLCP's overseas customers are spread out across several countries including Brazil, Argentina, China, Chile, Peru, Colombia, South Africa, Thailand, Australia, Israel, Netherlands and many others. The company has strong business relationships with number of prestigious clients such as Ranbaxy Labs, Aurbindo Pharma, Dr Reddy’s, DS Group, CIPLA, Uflex Industries, ITC Limited, ICI Paints, Asian Paints, Pidilite, Rallis India, Hindustan Polymide, Gujarat Super Phosphate, Avantis India Ltd., Macleods Pharma Ltd. etc. For more information on IOLCP, please visit http://www.iolcp.com

Also Read

First Published: Dec 15 2010 | 7:51 PM IST

Next Story